TGTXJPM2025Presentation1.13.25

FIERCELY FOCUSEDJanuary 2025J.P. Morgan Healthcare Conference 2Forward Looking Safe Harbor StatementThis presentation contains forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.Such forward looking statements include but are not limited to statements regarding expectations for success of our commercial launch and availability of BRIUMVI® (ublituximab-xiiy) for relapsing forms of multiple sclerosis (RMS); anticipated healthcare professional and patient acceptance and use of BRIUMVI for the FDA-approved indications, statements regarding the results of the ULTIMATE I & II Phase 3 studies as well as the long term safety study and BRIUMVI as a potential treatment for RMS and our statements regarding our potential revenue targets, operating expenses and cash position. Additional factors that could cause ou